BREAKING: Deadly Coronavirus Likely a Vaccine Strain: Report

UPDATE: Lyons-Weiler is now saying that there is clear evidence that SARS-CoV-2 is not a bioweapon and that it’s not likely a vaccine origin.

In a shocking report by Dr. James Lyons-Weiler, he lays out the probability that the deadly coronavirus which has been ravaging China and spreading across the globe is man-made.

After news of the outbreak spread in the international community, the Chinese government published the entire genome of the 2019-NCoV virus.

Researchers looked at the genome and couldn’t find a match in any known viruses in the medical database. It appears that the virus is typical of common bat coronavirus except for a small sequence, which appears to be inserted:

The added sequence was discovered to be identical to that of a sequence used in virology to make recombination vaccines (here’s the patent for its use). Specifically, it was used in a 2008 patent to develop a more effective coronavirus vaccine:

By means of biological engineering, the coronavirus S gene in combination with deficient recombinant adenovirus… can cause the gene vaccine, respiratory mucosal immune response induced by the body to produce antibodies against the virus infection.

Lyons-Weiler adds that the disease is what you’d expect given this type of manufactured origin:

The disease progression in of 2019-nCoV is consistent with those seen in animals and humans vaccinated against SARS and then challenged with re-infection. Thus, the hypothesis that 2019-nCoV is an experimental vaccine type must be seriously considered.

And:

The available evidence most strongly supports that the 2019-NCoV virus is a vaccine strain of coronavirus either accidentally released from a laboratory accident, perhaps a laboratory researcher becoming infected with the virus while conducting animal experiments, or the Chinese were performing clinical studies of a Coronavirus vaccine in humans.

As a result, Lyons-Weiler predicts that the outbreak will be much more deadly in the Chinese population—specifically in those who may have participated in a coronavirus vaccine trial—than in other countries.

Lyons-Weiler speaks to his findings on The Highwire: